0?" ".concat(t.layer):""," {")),o+=t.css,i&&(o+="}"),t.media&&(o+="}"),t.supports&&(o+="}");var r=t.sourceMap;r&&"undefined"!=typeof btoa&&(o+="\n/*# sourceMappingURL=data:application/json;base64,".concat(btoa(unescape(encodeURIComponent(JSON.stringify(r))))," */")),n.styleTagTransform(o,e,n.options)}(n,e,t)},remove:function(){!function(e){if(null===e.parentNode)return!1;e.parentNode.removeChild(e)}(n)}}}},589:function(e){e.exports=function(e,n){if(n.styleSheet)n.styleSheet.cssText=e;else{for(;n.firstChild;)n.removeChild(n.firstChild);n.appendChild(document.createTextNode(e))}}},559:function(e){e.exports=JSON.parse('[{"id":"search.voice.hover_clear_text","description":"","defaultMessage":"Clear"},{"id":"search.voice.hover_search_text","description":"","defaultMessage":"Search the web"},{"id":"search.voice.hover_voice_text","description":"","defaultMessage":"Search by voice"},{"id":"search.voice.permission_text","description":"","defaultMessage":"Allow microphone access to enable voice search"},{"id":"search.voice.permission_title","description":"","defaultMessage":"Waiting for permission"},{"id":"search.voice.recognition_error","description":"","defaultMessage":"Please check your microphone and audio levels."},{"id":"search.voice.recognition_listening","description":"","defaultMessage":"Listening..."},{"id":"search.voice.recognition_nomatch","description":"","defaultMessage":"Didn\'t get that."},{"id":"search.voice.recognition_retry","description":"","defaultMessage":"Try again."},{"id":"search.voice.recognition_start","description":"","defaultMessage":"What would you like to search for?"},{"id":"search.voice.trending_title","description":"","defaultMessage":"Try saying"},{"id":"search.voice.trending_or","description":"","defaultMessage":"or"}]')},336:function(e){e.exports=JSON.parse('["ar-JO","da-DK","de-AT","de-CH","de-DE","el-GR","en-AU","en-CA","en-GB","en-IN","en-MY","en-NZ","en-PH","en-SG","es-AR","es-CL","es-CO","es-ES","es-MX","es-US","fi-FI","fr-CA","fr-CH","fr-FR","id-ID","it-CH","it-IT","ko-KR","nb-NO","nl-NL","pl-PL","pt-BR","ro-RO","ru-RU","sv-SE","th-TH","tr-TR","vi-VN","zh-Hant-HK","zh-Hant-TW"]')}},v={};function y(e){var n=v[e];if(void 0!==n)return n.exports;var t=v[e]={id:e,exports:{}};return f[e](t,t.exports,y),t.exports}y.n=function(e){var n=e&&e.__esModule?function(){return e.default}:function(){return e};return y.d(n,{a:n}),n},y.d=function(e,n){for(var t in n)y.o(n,t)&&!y.o(e,t)&&Object.defineProperty(e,t,{enumerable:!0,get:n[t]})},y.o=function(e,n){return Object.prototype.hasOwnProperty.call(e,n)},y.nc=void 0,e=y(379),n=y.n(e),t=y(795),o=y.n(t),i=y(569),r=y.n(i),a=y(565),s=y.n(a),c=y(216),l=y.n(c),d=y(589),u=y.n(d),p=y(383),(h={}).styleTagTransform=u(),h.setAttributes=s(),h.insert=r().bind(null,"head"),h.domAPI=o(),h.insertStyleElement=l(),n()(p.Z,h),p.Z&&p.Z.locals&&p.Z.locals,m=y(516),function(e,n){var t={uiLang:"en-US",speechLang:"en-US",voiceButton:"#voice-btn",searchBox:{form:"#sf",input:"#yschsp",params:{fr:"",fr2:""}},enable_voice_trending:!1,trending:{market:"en-us"},ui:{speechOverlay:{disableBlur:!1}},browsers:{edge:!1}};function o(i){var r=this;if(r.config=Object.assign(t,i||{}),r.i18n=new o.I18n({lang:r.config.uiLang}),r.renderPermissionGuide(r),r.renderSpeechPanel(r),r.speechResult="",r.noSpeech=!0,r.isRecognitionStart=!1,r.recognition=null,r.voiceButton=n.querySelector(r.config.voiceButton),r.searchBoxForm=n.querySelector(r.config.searchBox.form),r.searchBoxQuery=n.querySelector(r.config.searchBox.input),r.speechPanel=n.querySelector("#spch"),r.speechButtonContainer=n.querySelector("#spchbc"),r.speechButton=n.querySelector("#spchbc-btn"),r.speechText=n.querySelector("#spcht"),r.speechOverlay=n.getElementById("spch-overlay"),r.retryLink=n.querySelector("#spcht-retry"),r.trending=n.getElementById("spch-trending"),r.trendingTerms=n.getElementById("trending-terms"),r.termSpans=n.getElementsByClassName("trending-term"),r.closeButton=n.querySelector("#spchx"),r.startAudio=new Audio("https://s.yimg.com/pv/static/misc/voice-start-202105050733.wav"),r.resultAudio=new Audio("https://s.yimg.com/pv/static/misc/voice-result-202105050733.wav"),r.errorAudio=new Audio("https://s.yimg.com/pv/static/misc/voice-error-202105050733.wav"),r.closeAudio=new Audio("https://s.yimg.com/pv/static/misc/voice-close-202105050733.wav"),r.permissionGuide=n.querySelector("#spchp"),r.permissionGuideClose=n.querySelector("#spchpx"),r.permissionGuideTimer=null,r.onEscKeyDown=function(e){"Escape"===e.code&&(r.recognition.stop(),r.sendBeacon("keybrd","voicesearch_cancel_esc"),r.closePanel(r))},r.isBrowserSupported()){var a=e.SpeechRecognition||e.webkitSpeechRecognition,s=e.SpeechGrammarList||e.webkitSpeechGrammarList;r.recognition=new a;var c=new s;c.addFromString&&c.addFromString("#JSGF V1.0;",1),r.recognition.grammars=c,r.recognition.continuous=!1,r.recognition.lang=r.config.speechLang,r.recognition.interimResults=!1,r.recognition.maxAlternatives=1,r.voiceButton&&(r.voiceButton.onclick=function(){r.recognition.start(),r.permissionGuideTimer&&e.clearTimeout(r.permissionGuideTimer),r.permissionGuideTimer=e.setTimeout((function(){r.isRecognitionStart||r.showPermissionGuide(r)}),300),n.addEventListener("keydown",r.onEscKeyDown),r.sendBeacon("clk","voicesearch")}),r.speechButton&&(r.speechButton.onclick=function(){r.isRecognitionStart?(r.recognition.stop(),r.sendBeacon("clk","voicesearch_panel_mic_close"),r.closePanel(r)):(r.recognition.start(),r.sendBeacon("clk","voicesearch_panel_mic_restart"))}),r.retryLink&&(r.retryLink.onclick=function(){r.isRecognitionStart||(r.recognition.start(),r.sendBeacon("clk","voicesearch_panel_retry"))}),r.speechOverlay&&(r.speechOverlay.onclick=function(){r.recognition.stop(),r.sendBeacon("clk","voicesearch_cancel_outside"),r.closePanel(r)}),r.closeButton&&(r.closeButton.onclick=function(){r.recognition.stop(),r.sendBeacon("clk","voicesearch_cancel"),r.closePanel(r)}),r.permissionGuideClose&&(r.permissionGuideClose.onclick=function(){r.recognition.stop(),r.sendBeacon("clk","voicesearch_permission_close"),r.closeAudio.play(),r.hidePermissionGuide(r)}),r.recognition.onresult=function(n){r.speechResult=n.results[0][0].transcript,r.handlePunctuation(r),r.speechText&&(r.speechText.innerText=r.speechResult),r.searchBoxQuery&&(r.searchBoxQuery.value=r.speechResult),r.resultAudio.play(),e.setTimeout((function(){if(r.speechPanel&&(r.speechPanel.classList.remove("s2tb"),r.speechPanel.classList.add("s2tb-h")),r.hideRetryLink(r),r.searchBoxForm){var e=r.searchBoxForm.querySelector("[name=fr]"),n=r.searchBoxForm.querySelector("[name=fr2]");e&&r.config.searchBox&&r.config.searchBox.params&&r.config.searchBox.params.fr&&(e.value=i.searchBox.params.fr,e.disabled=!1),n&&r.config.searchBox&&r.config.searchBox.params&&r.config.searchBox.params.fr2&&(n.value=i.searchBox.params.fr2,n.disabled=!1),r.searchBoxForm.submit()}}),1e3)},r.recognition.onspeechstart=function(){},r.recognition.onspeechend=function(){r.recognition.stop()},r.recognition.onerror=function(){r.speechText&&(r.speechText.innerText=r.i18n.t("search.voice.recognition_error")),r.hideTrending(r),r.showRetryLink(r),r.errorAudio.play()},r.recognition.onaudiostart=function(){r.speechButtonContainer&&r.speechButtonContainer.classList.add("listening")},r.recognition.onaudioend=function(){r.speechButtonContainer&&r.speechButtonContainer.classList.remove("listening")},r.recognition.onsoundstart=function(){r.hideTrending(r),r.noSpeech=!1,r.speechButtonContainer&&(r.speechButtonContainer.classList.remove("listening"),r.speechButtonContainer.classList.add("speaking"))},r.recognition.onsoundend=function(){r.speechButtonContainer&&r.speechButtonContainer.classList.remove("speaking")},r.recognition.onstart=function(){r.recognitionInit(r),r.startRecognition(r)},r.recognition.onend=function(){r.isRecognitionStart=!1,0==r.noSpeech&&""==r.speechResult&&(r.speechText&&(r.speechText.innerText=r.i18n.t("search.voice.recognition_nomatch")),r.hideTrending(r),r.showRetryLink(r),r.errorAudio.play())},document&&document.dispatchEvent&&document.dispatchEvent(new Event("VOICE_JS_READY"))}}o.I18n=m,o.prototype.renderPermissionGuide=function(e){var n='\n \n "),t=(new DOMParser).parseFromString(n,"text/html");document.body.appendChild(t.body.children[0])},o.prototype.renderSpeechPanel=function(e){var n='\n \n '),t=(new DOMParser).parseFromString(n,"text/html");e&&e.config&&e.config.ui&&e.config.ui.speechOverlay&&e.config.ui.speechOverlay.disableBlur&&t.body.children[0].classList.add("disable-blur-overlay"),document.body.appendChild(t.body.children[0])},o.prototype.isBrowserSupported=function(){for(var n=!1,t=this,o=Boolean(window.chrome),i=/CriOS/.test(window.navigator.userAgent),r=/Edg\//.test(window.navigator.userAgent),a=/Edge\//.test(window.navigator.userAgent),s=Boolean(window.opr),c=Boolean(window.navigator.brave),l=[{checkEnabled:function(){return!0},checkBrowser:function(){return o&&!i&&!r&&!s&&!c},checkAPI:function(){return e&&("SpeechRecognition"in e||"webkitSpeechRecognition"in e)&&("SpeechGrammarList"in e||"webkitSpeechGrammarList"in e)}},{checkEnabled:function(){return t&&t.config&&t.config.browsers&&t.config.browsers.edge},checkBrowser:function(){return o&&r&&!a},checkAPI:function(){return e&&("SpeechRecognition"in e||"webkitSpeechRecognition"in e)&&("SpeechGrammarList"in e||"webkitSpeechGrammarList"in e)}}],d=0;d0){var n=e.speechResult.charAt(e.speechResult.length-1);"."!==n&&"?"!==n&&"。"!==n&&"？"!==n||(e.speechResult=e.speechResult.slice(0,-1))}},o.prototype.sendBeacon=function(n,t){var o=e.YAHOO.ULT||{},i=e.YAHOO.SB||{};if(o.beacon_click){var r={_S:i.config.i13n.spaceid,_I:i.config.i13n.pvid,actn:n,sec:"search",slk:t};e.YAHOO.ULT.beacon_click(r)}},o.prototype.ajaxReq=function(t,o){var i,r,a=XMLHttpRequest.DONE||4,s=new XMLHttpRequest;if(n.documentMode&&n.documentMode<10)return(new e.XDomainRequest).onload=function(){try{r=JSON.parse(i),o(r)}catch(e){return}},s.open("GET",t),void s.send();s.onreadystatechange=function(){if(s.readyState===a)if(200===s.status){i=s.responseText;try{r=JSON.parse(i),o(r)}catch(e){return}}else o(r)},s.open("GET",t,!0),s.timeout=1e4,s.send()},e.YAHOO||(e.YAHOO={}),e.YAHOO.Util||(e.YAHOO.Util={}),e.YAHOO.Util.VoiceSearch=o}(window,document)}();var Wn={containerClass:Un.tooltip,textClass:Un.tooltip__text,showClass:Un["tooltip--show"]},Jn=["zh-hant-tw","zh-hant-hk"];ye("ybar-mod-searchbox",(function(e){var n={ybar:document.getElementById("ybar"),searchInput:document.getElementById("ybar-sbq"),buttonBar:document.querySelector(".".concat(Un["sa-btn-bar"])),voiceSearchBtn:document.getElementById("ybar-sbq-voice"),searchForm:document.getElementById("ybar-sf"),searchBoxIcon:document.querySelector(".".concat(Un["searchbox-icon-uh3"])),searchBoxPlaceholder:document.getElementById("ybar-smartphone-searchbox-placeholder"),searchBoxBackButton:document.getElementById("ybar-search-back-btn"),shopsButtonsWrap:document.querySelector(".".concat(Un["shops-buttons"])),categorySelect:document.getElementById("shops-category-select"),selectedMerchantInput:document.getElementById("selected-merchant-input"),selectedMerchantClearButton:document.querySelector(".".concat(Un["selected-merchant-clear-button"])),submitSearchBtn:document.getElementById("ybar-search"),clearSearchBtn:document.getElementById("ybar-sbq-x")};!function(e,n){var t,o,i,r=e.getConfig();if(n.ybar&&"desktop"===r.device&&(null===(t=r.bucketConfig)||void 0===t?void 0:t.highlight_searchassist)&&(null===(o=r.bucketConfig)||void 0===o?void 0:o.overlay_class)){n.ybar.setAttribute("data-ovrly-bkt",r.bucketConfig.overlay_class),null===(i=n.searchForm)||void 0===i||i.classList.add(Un[r.bucketConfig.overlay_class]);var a=document.createElement("div");a.classList.add(Un.overlay,Un[r.bucketConfig.overlay_class]),document.body.appendChild(a),e.onDestroy((function(){document.body.removeChild(a)})),e.addElementListener(n.searchForm,"focusout",(function(e){if(n.searchForm&&n.searchInput){var t=e.relatedTarget;t&&!n.searchForm.contains(t)&&window.YAHOO.SA&&window.YAHOO.SA.apps&&window.YAHOO.SA.apps[0]&&window.YAHOO.SA.apps[0].view.shown&&window.YAHOO.SA.apps[0].view.hide()}}))}}(e,n),Fn(e,n),n.voiceSearchBtn&&function(e,n){var t=e.getConfig(),o=t.locale,i=function(){var e,t;(null===(t=null===(e=window.YAHOO)||void 0===e?void 0:e.Util)||void 0===t?void 0:t.VoiceSearch)?new window.YAHOO.Util.VoiceSearch({uiLang:o,speechLang:o,voiceButton:"#ybar-sbq-voice",searchBox:{form:"#ybar-sf",input:"#ybar-sbq",params:{fr:n.voiceSearchBtn.dataset.fr||"yfp-t-voice",fr2:n.voiceSearchBtn.dataset.fr2||"p:fp,m:voice-search"}},ui:{speechOverlay:{disableBlur:Jn.includes(o.toLowerCase())}},browsers:{edge:!0},enable_voice_trending:!0,trending:{market:o}}):console.log("YBAR: VoiceJS lib was not loaded")};e.addElementListener(document,"VOICE_JS_READY",(function(){var o,i;n.voiceSearchBtn.style.visibility="visible",n.voiceSearchBtn.style.display="block",new Gn(e,n.voiceSearchBtn,h(h({},Wn),{label:null!==(o=t.i18n.root.SEARCH_TOOLTIP_VOICE)&&void 0!==o?o:"Search with voice",containerClass:"".concat(Un.tooltip," ").concat(Un.tooltip__voice),tooltipParentElm:null===(i=n.voiceSearchBtn)||void 0===i?void 0:i.parentElement}))})),e.addElementListener(document,"DOMContentLoaded",(function(){var o,i;new Gn(e,n.submitSearchBtn,h(h({},Wn),{label:null!==(o=t.i18n.root.SEARCH_TOOLTIP_WEB)&&void 0!==o?o:"Search the web",containerClass:"".concat(Un.tooltip," ").concat(Un.tooltip__web),tooltipParentElm:null===(i=n.voiceSearchBtn)||void 0===i?void 0:i.parentElement}))})),"loading"===document.readyState?e.addElementListener(document,"DOMContentLoaded",i):i(),window.addEventListener("keyup",(function(e){27===e.keyCode&&n.voiceSearchBtn.blur()}))}(e,h(h({},n),{voiceSearchBtn:n.voiceSearchBtn})),n.searchForm&&(e.addElementListener(n.searchBoxIcon,"mouseover",(function(){n.searchForm.classList.add("".concat(Un["search-input-uh3-hover"]))})),e.addElementListener(n.searchBoxIcon,"mouseout",(function(){n.searchForm.classList.remove("".concat(Un["search-input-uh3-hover"]))})),e.addElementListener(n.buttonBar,"mouseover",(function(){n.searchForm.classList.add("".concat(Un["search-input-uh3-hover"]))})),e.addElementListener(n.buttonBar,"mouseout",(function(){n.searchForm.classList.remove("".concat(Un["search-input-uh3-hover"]))})),e.addElementListener(n.searchInput,"keyup",(function(e){"Tab"===e.key&&n.searchForm.classList.add("".concat(Un["search-input-uh3-focus-visible"])),n.searchInput.classList.toggle("".concat(Un.empty),""===n.searchInput.value)})),e.addElementListener(n.searchInput,"keydown",(function(){n.searchForm.classList.remove("".concat(Un["search-input-uh3-focus-visible"]))})),e.addElementListener(n.searchInput,"focusout",(function(){n.searchForm.classList.remove("".concat(Un["search-input-uh3-focus-visible"]))})),e.addElementListener(n.submitSearchBtn,"click",(function(e){""===n.searchInput.value.trim()&&e.preventDefault()})),e.addElementListener(n.clearSearchBtn,"click",(function(){n.searchInput.classList.add("".concat(Un.empty))})))}));var Vn="_yb_b0lous",Xn="_yb_1sgm00k",Kn="_yb_1nlr5mp",Zn="_yb_b0739c",$n="_yb_6nej39",Qn="_yb_1uqq8lk",et="_yb_1qv8jto",nt="_yb_1vbvqrb";ye("ybar-mod-adaptivenav",(function(e){var n={moreDropDown:document.querySelector(".".concat(Vn)),moreBtn:document.querySelector(".".concat(Xn)),wrap:document.querySelector(".".concat(Zn)),moreSectionTitle:document.querySelectorAll(".".concat($n)),editionsCtaBtn:document.querySelector(".".concat(Qn)),editionsMenu:document.querySelector(".".concat(et)),closeBtn:document.querySelector(".".concat(nt))},t=!1,o=function(n,t){var o=n.moreDropDown,i=n.moreBtn,r=n.wrap,a={sec:"ybar",slk:"More",elm:"expand",pkgt:"top",subsec:"navrail",itc:"1"};o&&i&&r&&o.classList.contains("".concat(Vn))&&(o.classList.remove("".concat(Vn)),r.classList.add("".concat(Kn)),i.setAttribute("aria-expanded","true"),a.elm="expand",e.triggerEvent("adapnav:more:show",{event:t}),Q("ybar",a.slk,"",a))},i=function(e){var n=e.moreDropDown,o=e.moreBtn,i=e.wrap,r={sec:"ybar",slk:"More",elm:"close",pkgt:"top",subsec:"navrail",itc:"1"};n&&o&&i&&(n.classList.contains("".concat(Vn))||(n.classList.add("".concat(Vn)),i.classList.remove("".concat(Kn)),o.setAttribute("aria-expanded","false"),t||Q("ybar",r.slk,"",r)))},r=function(e){var n=e.editionsMenu,t={sec:"ybar",slk:"More",elm:"close",pkgt:"top",subsec:"navrail",itc:"1"};null==n||n.close(),Q("ybar",t.slk,"",t)},a=function(){var e;window.innerWidth<1024&&(null===(e=n.editionsMenu)||void 0===e||e.close())};n.moreBtn&&(e.addElementListener(n.moreBtn.parentNode,"focusin",(function(e){o(n,e)})),e.addElementListener(n.moreBtn.parentNode,"focusout",(function(){i(n)})),e.addElementListener(n.moreBtn,"mouseenter",(function(e){var t;window.YAHOO.SA&&window.YAHOO.SA.apps&&window.YAHOO.SA.apps[0]&&window.YAHOO.SA.apps[0].view.shown?window.YAHOO.SA.apps[0].view.hide():null===(t=n.moreBtn)||void 0===t||t.click(),o(n,e)})),e.addElementListener(n.moreBtn.parentNode,"mouseleave",(function(){i(n)})),e.addElementListener(n.moreBtn.parentNode,"click",(function(e){n.moreDropDown&&n.moreDropDown.classList.contains("".concat(Vn))&&o(n,e)})),e.addElementListener(n.moreBtn,"keydown",(function(e){var t;27===e.keyCode&&(null===(t=n.moreBtn)||void 0===t||t.blur())}))),n.moreSectionTitle&&Array.from(n.moreSectionTitle).forEach((function(n){e.addElementListener(n,"mouseover",(function(){t=!0})),e.addElementListener(n,"mouseout",(function(){t=!1}))})),n.editionsCtaBtn&&n.editionsMenu&&"function"==typeof HTMLDialogElement&&(n.editionsMenu.setAttribute("style",""),e.addElementListener(n.editionsCtaBtn,"click",(function(){var e,t;n.editionsMenu&&(e=n.editionsMenu,t={sec:"ybar",slk:"More",elm:"expand",pkgt:"top",subsec:"navrail",itc:"1"},e&&(e.showModal(),Q("ybar",t.slk,"",t)))})),e.addElementListener(n.closeBtn,"click",(function(){r(n)})),n.editionsMenu.addEventListener("click",(function(e){var t,o,i=null===(t=n.editionsMenu)||void 0===t?void 0:t.getBoundingClientRect();(e.clientXi.right||e.clientYi.bottom)&&(null===(o=n.editionsMenu)||void 0===o||o.close())})),window.addEventListener("resize",a)),e.onDestroy((function(){i(n),r(n),window.removeEventListener("resize",a)})),window.addEventListener("keyup",(function(e){27===e.keyCode&&i(n)}))}));var tt,ot,it,rt={"account-status-container":"_yb_1i7g3z8","accounts-container":"_yb_hkaqry","accounts-list":"_yb_dfobyj",chevron:"_yb_g79f3x",current:"_yb_1myhlz3",expanded:"_yb_hbnwk1",greetings:"_yb_1xnqzms","greetings-container":"_yb_1ofrkj2",hide:"_yb_1athdyu",mobile:"_yb_1kuj9xy",multiple:"_yb_xz2sva","loading-profile-wrapper":"_yb_6i6og8","loading-profile-button":"_yb_12l6b59","notification-container":"_yb_1s17235","pfs-container":"_yb_1qrw0d5","pfs-iframe":"_yb_1umta6i",show:"_yb_1at0oph","sign-in-menu":"_yb_19r0hn5","signed-in":"_yb_wfc2ry","signed-in-mark":"_yb_1tn3mc6","signed-out":"_yb_h0nxwn","signedout-text":"_yb_hsq8my","stacked-name":"_yb_qtahar","stacked-name-given":"_yb_16rhqi5","stacked-name-family":"_yb_kre6fc","uh3-layout":"_yb_rdgy8f","ybar-account-img":"_yb_jfv68s","ybar-account-img-signed-out":"_yb_2ljgow","ybar-account-img-hidden":"_yb_1zpjx7","ybar-account-menu":"_yb_105q40c","ybar-account-menu-item-signed-out":"_yb_1tmzlew","ybar-account-user-email":"_yb_19i5r7z","ybar-account-user-email-other":"_yb_2meakm","ybar-account-user-name":"_yb_1e6m1t0","ybar-account-user-signedout":"_yb_9durtr","ybar-account-yahoo-plus-imp":"_yb_1gl33up","ybar-icon-arrow":"_yb_1jr1f2k","ybar-icon-arrow-down":"_yb_3u20z7","ybar-icon-arrow-up":"_yb_8o9szo","ybar-icon-image-wrapper":"_yb_1fjern0","ybar-item-hidden":"_yb_dm3y1t","ybar-login-btn":"_yb_4lp6px","ybar-mod-account":"_yb_1of2ruh","ybar-mod-mail":"_yb_5camr5","ybar-profile-character":"_yb_g9khgs","ybar-profile-character-hidden":"_yb_dj49nv","ybar-see-info":"_yb_1scuazn","ybar-sign-out":"_yb_1v5zjgj","ybar-sign-out-text":"_yb_c3mpwz","ybar-user-accounts-list":"_yb_1war1ma","ybar-user-profile-img":"_yb_1dqqkyy"};tt="ybar",it={createHTML:function(e){return e}},void 0!==(ot=window.trustedTypes)&&void 0!==ot.createPolicy&&window.trustedTypes.createPolicy(tt,it);var at,st=!1,ct=function(e,n,t){var o,i=t.ybarAccMenuItemTemplate,r=t.crumb;if(i){var a=(n+1).toString(),s=i.getAttribute("data-signedOutState"),c=i.getAttribute("data-signedInState")||"",l=i.getAttribute("data-done")||"",d=function(e){if("content"in e)return e.content.cloneNode(!0);for(var n=document.createDocumentFragment(),t=0;t=230&&(e.greetings.classList.add(rt.hide),e.stackedName.classList.remove(rt.hide),e.chevron&&(e.chevron.style.marginTop="-35px"))},dt=function(e,n,t){return 0===e.indexOf("javascript:")||~e.indexOf("https://membernotifications.aol.com/notice/maillogout")||~e.indexOf("wtExtndSource")?e:(t&&(t=~e.indexOf("&activity=ybar-")?void 0:t.replace("[[pspid]]",ce())),~e.indexOf("done=")?(e=e.replace(/\[\[page\]\]/g,encodeURIComponent(window.location.href)),t&&(e+="&"+t),e):~e.indexOf("dest=[[done]]")?e.replace(/\[\[done\]\]/g,encodeURIComponent(n)):(e=de(e),e+=".done="+encodeURIComponent(n),t&&(e+="&"+t),e))},ut=function(e,n){var t,o=e.ybarAccMenuItemTemplate,i=e.ybarAccountContainer,r=document.querySelector(".".concat(rt["ybar-mod-account"]," .").concat(rt["ybar-login-btn"])),a=document.querySelector(".".concat(rt["ybar-mod-account"]," .").concat(rt["ybar-sign-out"])),s=i&&i.querySelectorAll("a"),c="",l=window.location.href;if(r){var d=r.href;n.onDestroy((function(){r.href=d})),r.href=dt(r.href,l,r.getAttribute("data-redirect-params")||void 0)}if(o?(l=o.getAttribute("data-done")||"",c=o.getAttribute("data-sign-out-url")||""):a&&(c=a.getAttribute("data-sign-out-url")||""),s){var u=function(){var e=t,o=s[e].href;n.onDestroy((function(){s[e].href=o}));var i=s[t].getAttribute("data-redirect-params");s[t].classList.contains(rt["ybar-sign-out"])?s[t].href=dt(s[t].href,c,i||void 0):s[t].href=dt(s[t].href,l,i||void 0)};for(t=0;t=0;--n){e[n]=(i=void 0,(i={fn:(o=e[n]).fn||"",ln:o.ln||"",em:o.em||"",alias:o.alias||"",imageUrl:o.imageUrl,state:o.state,fullName:null,identifier:""}).fullName=pe(i.fn,i.ln)?[i.ln,i.fn].join(""):[i.fn,i.ln].join(" "),i.identifier=i.em||i.alias,i);var t=e[n].state;0!==t&&"0"!==t||(window.YBAR&&window.YBAR.setUserEmail(e[n].em),at=e[n],e.splice(n,1)[0])}var o,i;return e}(r.users);if(n.isUH3Layout&&at){if(n.ybarLoadingProfileWrapper){var l=document.querySelector(".".concat(rt["ybar-profile-character-hidden"])),d=at.fn&&at.fn[0].toUpperCase()||"",u=pe(at.fn,at.ln),p=function(){n.ybarLoadingProfileWrapper.remove(),n.ybarAccountMenu.classList.remove(rt["loading-profile-button"])};if(l&&ue(at.imageUrl)&&!u)l.innerHTML=d,l.ontransitionend=p,l.classList.remove(rt["ybar-profile-character-hidden"]);else{var h=new Image;h.classList.add(rt["ybar-account-img"],rt["ybar-account-img-hidden"]),h.src=at.imageUrl,h.alt=n.ybarLoadingProfileWrapper.getAttribute("data-alt")||"",h.ontransitionend=p,h.onload=function(){h.classList.remove(rt["ybar-account-img-hidden"])},n.ybarLoadingProfileWrapper.parentElement.prepend(h),l&&l.remove()}n.greetings&&(n.greetings.innerText=at.fullName||""),n.stackedNameGiven&&(n.stackedNameGiven.innerText=at.fn||""),n.stackedNameFamily&&(n.stackedNameFamily.innerText=at.ln||""),lt(n)}c.length>0&&(c.unshift(at),n.chevron&&n.chevron.classList.remove("hide"),n.greetingsContainer&&(n.greetingsContainer.classList.add(rt.multiple),n.greetingsContainer.setAttribute("aria-expanded","false")))}for(var m=document.querySelector(".".concat(rt["ybar-user-accounts-list"]))||document.querySelector(".".concat(rt["accounts-list"])),f=function(t){var o=ct(c[t],t,n);o&&(null==m||m.appendChild(o)),e.onDestroy((function(){o&&(null==m||m.removeChild(o))}))},v=0;v0){var y=document.querySelector("".concat(s," .").concat(rt["ybar-sign-out"])),g=y&&y.getAttribute("data-soa"),b=document.querySelector("".concat(s," .").concat(rt["ybar-sign-out-text"]));if(b&&g&&(b.innerText=g),a&&a.classList.add(rt.show),t){var w=document.querySelector("".concat(s," ").concat(rt["ybar-icon-arrow"])),_=rt["ybar-icon-arrow-up"],L=rt["ybar-icon-arrow-down"],x=rt["ybar-item-hidden"],k=document.querySelectorAll(".".concat(rt["ybar-item-hidden"]));w&&(w.classList.toggle(L),e.addElementListener(w,"click",(function(){for(var e=0;e3){var E=document.querySelector("".concat(s," .").concat(rt["ybar-see-info"]));E&&E.style&&(E.style.display="block")}ut(n,e),o&&o(),st=!1}))}},ht=function(e,n,t){var o,i,r,a,s,c={},l=e.getConfig(),d=new URLSearchParams({activity_p:"ybar"}),u=null,p="https://pfs.yahoo.com",h=function(e){for(var n=e.split(";"),t=new Map,o=0;o567?567:e},y=function(){document.body.removeEventListener("focusin",y,!1),document.body.removeEventListener("click",y,!1),u&&(u.style.height="0",u.style.visibility="hidden")},g=function(){var e;if(null===(e=document.activeElement)||void 0===e?void 0:e.classList.contains(t))return document.body.addEventListener("focusin",y,!1),void document.body.addEventListener("click",y,!1);y()},b=function(){u&&(u.style.visibility="visible",m("resize",{height:f()}))},w=function(){if(null===u){(u=document.createElement("iframe")).src="".concat(p,"/?").concat(d.toString()),u.scrolling="no",u.sandbox.add("allow-forms"),u.sandbox.add("allow-scripts"),u.sandbox.add("allow-same-origin"),u.sandbox.add("allow-popups"),u.classList.add(t),u.style.visibility="visible",u.style.height="0px",u.style.transition="all 0.3s ease-in",u.style.opacity="0";var r=document.createElement("style");r.type="text/css",r.appendChild(document.createTextNode(".skeleton-container { display: inline-flex; padding: 20px 20px 41px 20px; justify-content: center; align-items: center; background: var(--UI-White, #FFF); }.profile-skeleton { display: flex; flex-direction: column; align-items: flex-start; gap: 14px; }.userinfo-container { display: flex; align-items: center; gap: 12px; }.avatar { width: 72px; height: 72px; border-radius: 8px; background: var(--Greyscale-14-Grey-Hair, #F0F3F5); }.userinfo { display: flex; padding: 8px 0px; flex-direction: column; align-items: flex-start; gap: 10px; }.name { width: 117px; height: 16px; border-radius: 8px; background: var(--Greyscale-14-Grey-Hair, #F0F3F5); }.email { width: 74px; height: 12px; border-radius: 8px; background: var(--Greyscale-14-Grey-Hair, #F0F3F5); }.manage-account { width: 284px; height: 40px; border-radius: 40px; opacity: 0.5; background: var(--Greyscale-14-Grey-Hair, #F0F3F5); }.list-container { display: flex; padding-top: 12px; flex-direction: column; align-items: flex-start; gap: 36px; align-self: stretch; opacity: 0.25; }.list { border-radius: 8px; background: var(--Greyscale-14-Grey-Hair, #F0F3F5); } .list:nth-child(1) { width: 198px; height: 12px; }.list:nth-child(2) { width: 169.5px; height: 12px; }.list:nth-child(3) { width: 198px; height: 12px; }")),u.addEventListener("load",(function(){setTimeout((function(){var t;o&&i||(e.triggerEvent("ybar-pfs-init-failure"),null===(t=null==u?void 0:u.parentNode)||void 0===t||t.removeChild(u),n.ybarAccountContainer&&n.ybarAccountContainer.setAttribute("data-pfs","err"))}),500)})),n.loggedInUserElement&&(n.loggedInUserElement.appendChild(u),u.contentDocument&&(u.contentDocument.head.appendChild(r),u.contentDocument.body.innerHTML='\n ',u.style.height="300px",u.style.width="324px",u.style.opacity="1",u.style.transition="all 0.3s ease-in"),e.addElementListener(n.loggedInUserElement,"mouseleave",g),e.addElementListener(n.loggedInUserElement,"blur",g),n.ybarAccountMenu&&(e.addElementListener(n.ybarAccountMenu.parentNode,"mouseenter",b),e.addElementListener(n.ybarAccountMenu.parentNode,"focus",b)))}};if(n.ybarAccountMenu){if(e.addElementListener(n.ybarAccountMenu.parentNode,"mouseenter",w,{once:!0}),e.addElementListener(n.ybarAccountMenu.parentNode,"focus",w,{once:!0}),e.onDestroy((function(){y(),u=null})),n.ybarAccountContainer)"false"===n.ybarAccountContainer.getAttribute("data-prod")&&(p="https://stage.pfs.yahoo.com"),d.set("intl","us"),d.set("src",l.property),d.set("lang",l.locale),d.set("theme",(r="light",a=document.documentElement,null!==(s=a.getAttribute("data-color-theme-enabled"))&&"false"!==s&&(r="dark"===a.getAttribute("data-color-scheme")?"dark":"auto"),r)),d.set("done",window.location.href),d.set("pspid",ce());window.addEventListener("message",(function(e){if(e.origin===p){var n=function(e){var n={cmd:"noop",params:{height:"0px",width:"",url:"","data-ylk":""}};try{n=JSON.parse(e)}catch(e){return}return n}(e.data);if(null!==u&&(null==n?void 0:n.cmd)&&e.source&&!(e.source instanceof MessagePort)&&!(e.source instanceof ServiceWorker))switch(n.cmd){case"iframeready":o=e.origin,i=e.source,m("initialize",{height:f(),maxAccounts:3,enableAnimations:!0,animationDuration:"500ms",animationTimingFunction:"ease-in-out"});break;case"hide":case"hide-for-animation":u.style.height="0";break;case"show":u.style.height=n.params.height,u.style.visibility="0"===n.params.height?"hidden":"visible",n.params.width&&(u.style.width=n.params.width);break;case"redirect":c=h(n.params["data-ylk"]),Q("ybar",c.slk||"account","",c),window.location=n.params.url;break;case"popup":c=h(n.params["data-ylk"]),Q("ybar",c.slk||"account","",c),window.open(n.params.url,"_blank")}}})),window.addEventListener("keyup",(function(e){if(!u||"visible"===u.style.visibility){27===e.keyCode&&g()}}))}},mt=null,ft=!0,vt=0,yt={ybarAccountImage:{selector:"ybar-account-img",size:"64"},ybarCurrentUserProfileImage:{selector:"ybar-current-user-profile-img",size:"128"},ybarUserProfileImage:{selector:"ybar-user-profile-img",size:"128"}};ye("ybar-account-init",(function(e){var n=document.getElementById("ybarAccountContainer");!function(e,n){var t=n.ybarAccountContainer,o=n.ybarAccountMenu,i=n.ybarMobile,r=n.ybarMenuManagePub,a=n.signInAccountMenu,s=n.signInBtn,l=n.ybarModAccount,d=n.yahooPlusImpression,u=n.chevron,p=n.greetingsContainer,h=n.accountsContainer,m=n.ybarLabel,f=function(){new Ge(e,{containerElm:n.ybarAccountContainer,isUserAccountNavigation:!0,loggedInUser:n.loggedInUser,loggedInUserElement:n.loggedInUserElement,accountSwitcherButtonSelector:".".concat(rt["greetings-container"],".").concat(rt.multiple)})},v=function(o){if(t)t.style.removeProperty("display"),"false"===t.getAttribute("data-enabled")&&(t.style.display="none"),ut(n,e);else{var i=new Error("ybarAccountContainer not Found");c("ERROR:",i)}t&&ft&&(ft=!1,e.onDestroy((function(){ft=!0})),pt(e,n,o,f))},y=function(){var e,n;0===vt&&(vt=1,null===(e=null==o?void 0:o.parentNode)||void 0===e||e.removeEventListener("mouseenter",y),null===(n=null==o?void 0:o.parentNode)||void 0===n||n.removeEventListener("focusin",y),setTimeout((function(){ee()}),500))},g=function(n){(null==t?void 0:t.classList.contains("ybarMenuOpen"))||(null==o?void 0:o.classList.contains(rt["loading-profile-button"]))||(null==t||t.classList.add("ybarMenuOpen"),null==o||o.setAttribute("aria-expanded","true"),e.triggerEvent("profile:show",{event:n}))},b=function(n){if(o&&t){if(o.classList.contains(rt["loading-profile-button"]))return;t.classList.contains("ybarMenuOpen")?(t.classList.remove("ybarMenuOpen"),null==o||o.setAttribute("aria-expanded","false")):(t.classList.add("ybarMenuOpen"),o.setAttribute("aria-expanded","true"),e.triggerEvent("profile:show",{event:n}))}},w=function(){null==t||t.classList.remove("ybarMenuOpen"),null==o||o.setAttribute("aria-expanded","false")},_=function(){window.YAHOO.SA&&window.YAHOO.SA.apps&&window.YAHOO.SA.apps[0]&&window.YAHOO.SA.apps[0].view.shown&&window.YAHOO.SA.apps[0].view.hide()},L=function(e){27===e.keyCode&&(w(),null==m||m.blur())},x=function(){if(d&&!d.getAttribute("src")&&d.getAttribute("data-src")){var n=d.getAttribute("data-src")||"";Ke(n).then((function(e){null===mt&&((mt=document.createElement("iframe")).src="https://s.yimg.com/jk/gtm/gtm_ns.html?id=GTM-NVQTVCX&type=yahoo&cat=ybarimp1",mt.sandbox.add("allow-scripts"),mt.sandbox.add("allow-same-origin"),mt.height="0",mt.width="0",mt.referrerPolicy="origin",mt.style.display="none",mt.style.visibility="hidden",document.body.appendChild(mt)),d.setAttribute("src",e)})),e.onDestroy((function(){d.setAttribute("src",""),mt=null}))}};lt(n),s&&(Ee(e,s,"ybar","sign-in",{elm:"signin",subsec:"settings",itc:"2"}),ut(n,e));var k=function(){v(!1),e.addEventListener("close-all-menus",(function(){a&&a.classList.contains(rt.show)&&a.parentNode&&!xe(a.parentNode)&&w()})),h&&u&&p&&e.addElementListener(p,"click",(function(e){e.stopPropagation(),p.classList.contains(rt.multiple)&&(h.classList.contains("hide")?(u.classList.add(rt.expanded),h.classList.remove("hide"),p.setAttribute("aria-expanded","true")):(u.classList.remove(rt.expanded),h.classList.add("hide"),p.setAttribute("aria-expanded","false"),p.setAttribute("aria-label",p.getAttribute("data-label")||"")))})),e.onDestroy((function(){w()})),o&&(o.onchange=function(){e.triggerEvent("close-all-menus")},{itc:"2",elm:"menu",elmt:"user-info",subsec:"accounts"},l&&(e.addElementListener(l,"mouseenter",x),e.addElementListener(l,"focus",x)),o&&o.parentNode&&(e.addElementListener(o.parentNode,"mouseenter",y),e.addElementListener(o.parentNode,"focusin",y)),Se("#ybarAccountMenu","#ybarAccountMenu + label",e)),e.addElementListener(l,"focusin",g),e.addElementListener(l,"focusout",w),e.addElementListener(l,"click",b),e.addElementListener(l,"mouseenter",b),e.addElementListener(l,"mouseleave",w),e.addElementListener(r,"click",w),e.addElementListener(l,"mouseenter",_),e.addElementListener(l,"keydown",L)};if(o||i||a){if(i)v(!0);else{if(t&&"true"===t.getAttribute("data-pfs"))return ht(e,n,rt["pfs-iframe"]),void e.addEventListener("ybar-pfs-init-failure",(function(){var e;null===(e=n.ybarAccountMenuBody)||void 0===e||e.classList.remove(rt["pfs-container"]),k(),Q("ybar","pfs-load-failure","",{elm:"btn",subsec:"profile",itc:"1"})}));k()}Object.keys(yt).forEach((function(e){var n=yt[e],t=document.querySelector(".".concat(rt[n.selector]));t&&(t.onerror=function(){var e,o;o="https://s.yimg.com/cv/apiv2/ybar/images/default_user_profile_pic_"+n.size+".svg",(e=t).onerror=null,e.srcset="",e.src=o})}))}window.addEventListener("keyup",L)}(e,{ybarAccountContainer:n,ybarAccountMenu:document.getElementById("ybarAccountMenu"),loggedInUser:document.querySelectorAll("#ybarAccountProfile"),loggedInUserElement:document.getElementById("ybarAccountProfile"),ybarMobile:document.querySelector(".".concat(rt.mobile," .").concat(rt["ybar-account-user-email"])),ybarMenuManagePub:document.getElementById("ybarMenuManagePub"),signInAccountMenu:document.querySelector(".".concat(rt["ybar-mod-account"]," .").concat(rt["sign-in-menu"])),signInBtn:document.querySelector(".".concat(rt["ybar-mod-account"]," .").concat(rt["ybar-login-btn"])),ybarModAccount:document.querySelector(".".concat(rt["ybar-mod-account"])),yahooPlusImpression:n&&n.querySelector(".".concat(rt["ybar-account-yahoo-plus-imp"])),crumb:document.querySelector('input[name="uh-crumb"]'),ybarAccMenuItemTemplate:document.getElementById("ybarAccMenuItemTemplate"),isUH3Layout:!!document.querySelector(".".concat(rt["uh3-layout"])),chevron:document.querySelector(".".concat(rt.chevron)),accountsContainer:document.querySelector(".".concat(rt["accounts-container"])),greetingsContainer:document.querySelector(".".concat(rt["greetings-container"])),ybarAccountMenuBody:document.getElementById("ybarAccountMenuBody"),greetings:document.querySelector(".".concat(rt.greetings)),stackedName:document.querySelector(".".concat(rt["stacked-name"])),stackedNameGiven:document.querySelector(".".concat(rt["stacked-name-given"])),stackedNameFamily:document.querySelector(".".concat(rt["stacked-name-family"])),ybarLabel:document.querySelector("#ybarAccountMenuOpener"),ybarLoadingProfileWrapper:document.querySelector(".".concat(rt["loading-profile-wrapper"]))})}));var gt={"popover-body":"_yb_1tk9txe","ybar-mail-link":"_yb_1bhhqnz","ybar-mail-preview":"_yb_1umimk5","ybar-mail-signin-link":"_yb_1c9pgfa","ybar-mod-mail":"_yb_1cj6uzd","ybar-mod-mail-promo-imp":"_yb_1cdxgzm","ybar-large-unread":"_yb_17c0iyq","ybar-mid-unread":"_yb_9kf9gf","ybar-mail-indicator":"_yb_dq5d6m","ybar-unread-active":"_yb_1eyvrkj","count-loaded":"_yb_1nmuk8n"},bt=function(e){var n,t;null===(n=e.mailPreview)||void 0===n||n.classList.add("ybarMenuOpen"),null===(t=e.mailLink)||void 0===t||t.setAttribute("aria-expanded","true")},wt=function(e){var n,t;null===(n=e.mailPreview)||void 0===n||n.classList.remove("ybarMenuOpen"),null===(t=e.mailLink)||void 0===t||t.setAttribute("aria-expanded","false")},_t=function(e,n,t){var o=n.mailLink,i=n.mailUnread,r=n.mailUnreadSpan,a=n.mailIndicator,s="".concat(gt["ybar-unread-active"]);t.fetchCount().then((function(n){if(i&&n>0){var t=e.getConfig(),c=t.i18n.root.MAIL_ARIA_LINK;if(o&&o.hasAttribute("aria-label")&&c&&o.setAttribute("aria-label",c.replace("{count}",n.toString())),"finance"!==t.property&&i.classList.add(s),a&&a.classList.add(s),r){var l=n>99;r.textContent=l?"99+":n+"",i.classList.add("".concat(gt["count-loaded"])),l?i.classList.add("".concat(gt["ybar-large-unread"])):n>=10&&i.classList.add("".concat(gt["ybar-mid-unread"]))}e.onDestroy((function(){i.classList.remove(s),a&&a.classList.remove(s),r&&(r.textContent="")}))}})).catch((function(){}))};ye("ybar-mail-init",(function(e){var n=document.getElementById("ybarUnread");!function(e,n){var t=n.mailModule,o=n.mailLink,i=n.mailSigninLink,r=n.mailPreview;if(t){var a=new Pn;if(e.addElementListener(t,"mouseenter",(function(){e.triggerEvent("close-all-menus")})),e.addEventListener("close-all-menus",(function(){xe(t)||wt(n)})),e.addElementListener(r,"focusin",(function(){bt(n)})),e.addElementListener(r,"focusout",(function(){wt(n)})),e.onDestroy((function(){wt(n)})),i){var s=o.getAttribute("data-redirect-params");if(s&&""!==s){var c=o.href;e.onDestroy((function(){o.href=c})),s=-1!==o.href.indexOf("&activity=ybar-")?"":s.replace(/\[\[pspid\]\]/,ce()),o.href=de(o.href)+s,(null==i?void 0:i.href)&&(i.href=de(i.href)+s)}}else _t(e,n,a)}}(e,{mailModule:document.querySelector(".".concat(gt["ybar-mod-mail"])),mailIndicator:document.querySelector(".".concat(gt["ybar-mail-indicator"])),mailLink:document.querySelector(".".concat(gt["ybar-mail-link"])),mailSigninLink:document.querySelector(".".concat(gt["ybar-mail-signin-link"])),mailUnread:n,mailUnreadSpan:null==n?void 0:n.querySelector("span"),mailPreview:document.getElementById("ybarMailPreview"),popoverBody:document.querySelector(".".concat(gt["popover-body"].split(" ").join("."))),mailPreviewPopover:document.querySelector(".".concat(gt["ybar-mail-preview"].split(" ").join(".")," .").concat(gt["popover-body"].split(" ").join(".")))})}));var Lt,xt="_yb_34855r",kt="_yb_16uxic8",Et="_yb_wn1dn4",St="_yb_cdizfc",Ct="_yb_ho0h15",At="_yb_ydhj8u",Mt="_yb_2mzr0x",Nt="_yb_9qiv1m",It="_yb_13hvwg3",Tt="_yb_4x0qvu",Bt=function(e){var n=document.querySelector("#ybar-navigation-item-mail"),t=document.querySelector("#ybar-navigation-item-mail > a"),o=document.querySelector("#ybar-navigation-item-mail > a > span");null!==n&&null!==t&&(new Pn).fetchCount().then((function(n){o&&n>0&&(o.textContent="("+(n>99?"99+":n)+")",e.onDestroy((function(){o.textContent=""})))})).catch((function(){}))},Ot=!1,qt=-1,Pt=function(e,n,t){var o,i,r,a=-1,s=0;if(e.ybarNav&&e.navList){var c=window.getComputedStyle(e.ybarNav),l=parseInt(c.width,10)-parseInt(c.paddingLeft,10)-parseInt(c.paddingRight,10),d=61,u=e.navigationPlacement();if(u)d+=u.getBoundingClientRect().width;for(var p=window.getComputedStyle(e.navList),h=parseInt(p.gap,10)||0,m=0;mb&&(m!==e.navItems.length-1||s+y>b||e.moreMenuDropdown&&e.moreMenuDropdown.hasChildNodes()&&qt<0)){a=m;break}s+=y+(mqt&&-1!==qt)for(var _=qt;_=a;){var x=e.navItems[L].cloneNode(!0),k=x.querySelector("a");k&&(k.setAttribute("id",""),k.classList.remove(Et));var E=x.querySelector(".".concat(e.navigationDropdownListClass));if(E&&(E.style.display="none"),x.classList.remove(e.dropdownWrapperClass),x.classList.remove(e.ybarNavigationItemClass),x.classList.add(e.navigationDropdownItemClass),e.moreMenuDropdown){e.moreMenuDropdown.insertBefore(x,e.moreMenuDropdown.firstChild);var S=x.getElementsByTagName("a")[0];t.unshiftMoreMenuItem(S)}null===(r=e.navItems[L].querySelector("a"))||void 0===r||r.setAttribute("tabindex","-1"),L--}qt=a}if(-1!==a&&e.navList){var C=parseInt(s.toString(),10)+"px";e.navList.style.maxWidth=C,n.textContent=".".concat(Mt,"{ max-width: ").concat(C,"}")}e.moreMenuNavItem&&e.moreMenuDropdown&&e.moreMenuDropdown.hasChildNodes()?(e.moreMenuNavItem.classList.add(e.dropdownWrapperClass),e.moreMenuNavItem.style.visibility="visible"):null!==e.moreMenuNavItem&&(e.moreMenuNavItem.classList.remove(e.dropdownWrapperClass),e.moreMenuNavItem.style.visibility="hidden"),e.moreMenuDropdown&&e.moreMenuDropdown.childElementCount>10?e.moreMenuDropdown.classList.add(e.longListClass):null!==e.moreMenuDropdown&&e.moreMenuDropdown.classList.remove(e.longListClass)}},Rt=function(e,n,t,o){for(var i=n||window.location.pathname,r=t||window.location.hostname,a=(o||{}).setParentFocus,s=void 0!==a&&a,c=y([],v(e.topLevelNavLinks),!1),l=null,d=null,u=0;u0),r=new Ge(e,{containerElm:n.ybarNav,navlistItemSelector:".".concat(It," > li"),dropdownClass:n.dropdownWrapperClass,enableMoreMenu:i,moreMenuNavElm:n.moreMenuMainFocusItem,isUserAccountNavigation:!1});!function(e,n){var t;y([],v(null===(t=n.ybarNav)||void 0===t?void 0:t.querySelectorAll(".".concat(n.dropdownOpenClass))),!1).forEach((function(e){return e.classList.remove(n.dropdownOpenClass)}));var o=e.getConfig();"news"===o.property?Lt=-12:(Lt="finance"!==o.property&&"sports"!==o.property&&n.shiftMoreMenuEnabled?-24:-16,"zh-Hant-HK"!==o.locale&&"zh-Hant-TW"!==o.locale||(Lt=-20));var i=n.isTablet?"touchstart":"mouseover",r=je(".".concat(n.dropdownWrapperClass,", .").concat(n.navigationDropdownListClass),i,(function(t){if(window||document){var o=window.innerWidth||document.documentElement.clientWidth,i=t.delegateTarget;if(i&&-1!=i.className.indexOf(n.dropdownWrapperClass)&&(i=i.querySelector(".".concat(n.navigationDropdownListClass))),i){i.style.removeProperty("left");var r=i.getBoundingClientRect(),a=Math.trunc(r.right),s=parseInt(window.getComputedStyle(i).marginLeft,10)+o-a;if(a>o)return void(i.style.marginLeft=s+"px");parseInt(i.style.marginLeft)0?i.style.removeProperty("margin-left"):i.style.marginLeft=s+"px":(i.style.removeProperty("margin-left"),i.style.marginLeft=Lt+"px")}}else{var c=new Error("Dropdown could not be initialized");e.logError("Error:",c)}}));e.onDestroy((function(){r.destroy()}))}(e,n),Bt(e),e.addElementListener(document,"DOMContentLoaded",(function(){Bt(e)})),function(e,n){var t=function(e,t){var o;e.classList.contains(n.moreMenuNavItemClass)&&(null===(o=n.moreMenuMainFocusItem)||void 0===o||o.setAttribute("aria-expanded",t))},o=je(".".concat(n.dropdownWrapperClass),"focusin",(function(e){var o=e.delegateTarget;o&&o.classList.contains(n.dropdownWrapperClass)&&(o.classList.add(n.dropdownOpenClass),t(o,"true"))})),i=je(".".concat(n.dropdownWrapperClass,", .").concat(n.navigationDropdownListClass),"focusout",(function(e){var o=e.delegateTarget;if(null==o?void 0:o.classList.contains(n.navigationDropdownListClass)){var i=o.parentElement;i&&!i.contains(e.relatedTarget)&&i.classList.contains(n.dropdownWrapperClass)&&(i.classList.remove(n.dropdownOpenClass),t(i,"false"))}else(null==o?void 0:o.classList.contains(n.dropdownOpenClass))&&(o.classList.remove(n.dropdownOpenClass),t(o,"false"))}));e.onDestroy((function(){var e;o.destroy(),i.destroy(),y([],v(null===(e=n.ybarNav)||void 0===e?void 0:e.querySelectorAll(".".concat(n.dropdownOpenClass))),!1).forEach((function(e){e.classList.remove(n.dropdownOpenClass);var t=document.activeElement;(function(e,n){var t=!1;if(!e||!n)return t;if("function"==typeof e.contains)t=e.contains(n);else for(var o=n;o;){if(o===e){t=!0;break}o=o.parentElement}return t})(n.ybarNav,t)&&setTimeout((function(){null==t||t.blur()}),1)}))}))}(e,n);var a=e.getConfig().bucketConfig,s=void 0===a?{}:a,c=s.enableDynamicNavfocus,l=void 0!==c&&c,d=s.enableFuzzyMatching;if(l&&(Ot=void 0!==d&&d,Rt(n)),e.addEventListener("nav:setFocus",(function(e){var t=e.detail,o=void 0===t?{}:t,i=o.hostname,r=void 0===i?window.location.hostname:i,a=o.pathname,s=void 0===a?window.location.pathname:a,c=o.options;Rt(n,s,r,void 0===c?{}:c)})),i){var u=document.createElement("style");u.title="ybar_nav_interim",document.head.appendChild(u);var p=je("#ybar-nav-more-menu ul a","click",(function(n){e.triggerEvent("navigation",{event:n})}));e.addEventListener("nav:resize",(function(){Pt(n,u,r)})),Pt(n,u,r);var h=e.getConfig();e.addElementListener(window,"load",(function(){if(n.navList&&n.moreMenuNavItem&&(n.hasNavPlacement||Ht(e,n))){var t=[n.navList,n.moreMenuNavItem,n.hasNavPlacement];"sports"!==h.property&&t.forEach((function(e){e&&(e.style.opacity="1",e.style.visibility="visible")})),Pt(n,u,r)}})),e.addElementListener(window,"resize",(function(){Pt(n,u,r)})),e.onDestroy((function(){var e=u.parentNode;null==e||e.removeChild(u),p.destroy()}))}Ut(e,n)},Ht=function(e,n){var t=["zh-Hant-TW","zh-Hant-HK"].includes(e.getConfig().locale);return n.isFuji2&&t},Ut=function(e,n){if(n.isNavHidden){var t=!1;e.addElementListener(document,"DOMContentLoaded",(function(t){n.isNavHidden()&&e.triggerEvent("l2:hide",{event:t})})),e.addElementListener(window,"resize",(function(o){!t&&n.isNavHidden()&&e.triggerEvent("l2:hide",{event:o}),t=n.isNavHidden()}))}},Yt="#ybar-nav-more-menu";ye("ybar-mod-navigation",(function(e){var n,t=e.getConfig(),o={dropdownWrapperClass:kt,isFuji2:null!==document.querySelector(".ybar-ytheme-fuji2")||null!==document.querySelector(".ybar-ytheme-crunch"),isTablet:null!==document.querySelector(".tablet"),longListClass:St,moreMenuDropdown:document.querySelector("".concat(Yt," ul")),moreMenuNavItem:document.querySelector(Yt),moreMenuNavLinksSelector:"".concat(Yt," ul a"),moreMenuMainFocusItem:document.querySelector("".concat(Yt," > button")),moreMenuNavItemClass:Tt,navigationDropdownItemClass:Ct,navigationDropdownListClass:At,navItems:document.querySelectorAll("li.".concat(Nt)),topLevelNavLinks:document.querySelectorAll("li.".concat(Nt," > a")),navLinks:document.querySelectorAll(".ybar-mod-navigation a"),navList:document.querySelector(".ybar-mod-navigation ul"),shiftMoreMenuEnabled:document.querySelector(".ybar-shift-more-menu"),ybarNav:document.getElementById("ybar-navigation"),ybarNavigationItemClass:Nt,dropdownOpenClass:xt,hasNavPlacement:document.getElementById("ybar-nav-placement"),marginOffset:function(e){var n=window.getComputedStyle(e),o=parseInt(n.marginLeft,10)+parseInt(n.marginRight,10);return"sports"===t.property?parseInt(n.marginRight):"finance"===t.property&&"crunch"===t.ytheme?(o-=1.8)>5?o:5:"crunch"===t.ytheme?o:0},navigationPlacement:function(){return n||(n=document.getElementById("ybar-nav-placement")),n},isNavHidden:function(){var e=!1;return"finance"===t.property&&"crunch"===t.ytheme&&document.documentElement.clientWidth<=1049&&(e=!0),e}};o.ybarNav&&Dt(e,o)}));var jt="_yb_c3q9qr",zt="_yb_17d889j",Ft="_yb_efo4px",Gt="_yb_1h9mi0h",Wt="ytlv",Jt=864e5,Vt="_yb_qatcnl",Xt="_yb_1shfl9l",Kt="_yb_zrjsy3",Zt="_yb_yyul23",$t=function(){function e(e,n){var t=this;this.initialized=!1,this.ybar=e,this.container=n,this.a11yMenu=this.container.querySelector(".".concat(Zt)),this.historyEnabled=!!Number(this.container.dataset.history);var o=this.getLocalStorage();this.state={lastSeen:(null==o?void 0:o.lastSeen)||null,manuallyClosed:(null==o?void 0:o.manuallyClosed)||!1},this.init();var i=0,r=setInterval((function(){i>=5||t.initialized?clearInterval(r):(void 0!==t.isNotificationsSupported()&&t.init(),i++)}),100)}return e.prototype.show=function(e){var n;this.initialized&&(this.historyEnabled&&!e||(document.body.classList.add(Vt),null===(n=this.a11yMenu)||void 0===n||n.setAttribute("aria-expanded","true"),this.lastSeen=(new Date).getTime()))},e.prototype.hide=function(){var e;this.initialized&&(this.historyEnabled&&document.body.classList.remove(Xt),document.body.classList.remove(Vt),null===(e=this.a11yMenu)||void 0===e||e.setAttribute("aria-expanded","false"))},Object.defineProperty(e.prototype,"lastSeen",{get:function(){return this.state.lastSeen},set:function(e){this.state.lastSeen=e,this.setLocalStorage()},enumerable:!1,configurable:!0}),Object.defineProperty(e.prototype,"manuallyClosed",{get:function(){return this.state.manuallyClosed},set:function(e){this.state.manuallyClosed=!!e,this.setLocalStorage()},enumerable:!1,configurable:!0}),e.prototype.init=function(){this.isNotificationsSupported()&&this.isNotificationPermissionDefault()&&(this.historyEnabled||document.body.classList.add(Xt),this.addEventListeners(),this.initialized=!0,this.hasSeenTooltipIn(this.manuallyClosed?6048e5:Jt)||(document.body.classList.add(Xt),this.show(!0)))},e.prototype.addEventListeners=function(){var e=this;this.ybar.addElementListener(this.container.getElementsByClassName(Kt)[0],"click",(function(){e.hide(),e.manuallyClosed=!0}))},e.prototype.isNotificationsSupported=function(){var e;return null===(e=null===window||void 0===window?void 0:window.subscriptionHelperInstance)||void 0===e?void 0:e.checkIsSupportedBrowser()},e.prototype.isNotificationPermissionDefault=function(){var e;return"default"===(null===(e=window.Notification)||void 0===e?void 0:e.permission)},e.prototype.hasSeenTooltipIn=function(e){if(!this.lastSeen)return!1;var n=new Date(this.lastSeen),t=new Date;return n.getTime()+e>t.getTime()},e.prototype.setLocalStorage=function(){var e;null===(e=window.localStorage)||void 0===e||e.setItem(Wt,JSON.stringify(this.state))},e.prototype.getLocalStorage=function(){var e,n,t=null===(e=window.localStorage)||void 0===e?void 0:e.getItem(Wt);if(null===t)return null;try{return JSON.parse(t)}catch(e){return null===(n=window.localStorage)||void 0===n||n.removeItem(Wt),null}},e}(),Qt=-1,eo={0:0,1:1,9:9,99:99,150:150},no=function(e,n){var t,o=n.isUH3,i=n.notifMenu,r=n.notifMenuOpener,a=n.notifDropdown,s=n.notifBadge,c=n.notifContainer,l=n.notifLabel;n.tooltipContainer&&(t=new $t(e,n.tooltipContainer));var d=G(),u=function(){i&&(i.checked=!1),null==a||a.classList.remove("ybarMenuOpen")},p=function(){var n;e.triggerEvent("close-all-menus"),!!document.querySelector(".display-push-promos .".concat(jt))||(d.resetBadge(),s&&(o?null===(n=s.parentElement)||void 0===n||n.classList.remove(zt):s.style.display="none"))},h=function(e){var n,t;0===Qt&&(null===(n=null==e?void 0:e.css)||void 0===n?void 0:n.length)&&e.css.length>0&&(Qt++,function(e){for(var n,t,o=0;o0&&s)if(o){var r,a=(r=e.newCount)>99;s.textContent=a?"99+":r+"",null===(t=s.parentElement)||void 0===t||t.classList.add(zt)}else s.style.display="block"},m=function(){d.refreshPanel().then(h).then(ee).catch((function(){}))};e.addEventListener("close-all-menus",(function(){xe(c)||u()})),c&&(m(),setInterval((function(){m()}),3e5),o?l&&l.addEventListener("mouseenter",(function(){p(),null==t||t.show()})):c.addEventListener("mouseenter",(function(){p(),null==t||t.show()})),c.addEventListener("mouseleave",(function(){u(),null==t||t.hide()}))),e.addElementListener(i,"click",(function(){Q("ybar","notification","",{elm:"btn",elmt:"block"===(null==s?void 0:s.style.display)?"newalert":"",subsec:"notification",itc:"1"})})),r&&Ee(e,r,"ybar","notification",{elm:"expand",subsec:"notifications",itc:"2"}),e.addElementListener(a,"focusin",(function(){i&&(i.checked=!0),null==a||a.classList.add("ybarMenuOpen")})),e.addElementListener(a,"focusout",u),e.addElementListener(n.tooltipContainer,"focusin",(function(){null==t||t.show()})),e.addElementListener(n.tooltipContainer,"focusout",(function(){null==t||t.hide()}));var f=e.getConfig().device,v=document.getElementById("ybar");v&&v.classList.contains("ybar-ytheme-crunch")&&(Qt=0);var y=new RegExp("[?&]notifications=1(&|#|$)");"desktop"===f&&i&&y.test(window.location.search)&&(i.checked=!0)};ye("ybar-mod-notification",(function(e){var n={isUH3:"crunch"===e.getConfig().ytheme,notifContainer:document.getElementById("notification-container"),notifBadge:document.getElementById("notif-badge"),notifMenu:document.getElementById("ybarNotificationMenu"),notifMenuOpener:document.querySelector("#ybarNotificationMenu + label"),notifDropdown:document.getElementById("notifDropdownContainer"),tooltipContainer:document.querySelector(".".concat(Ft)),notifLabel:document.querySelector(".".concat(Gt))};no(e,n)}))}()}};
\n
\n
\n
\n
\n
\n
\n
'.concat(e.i18n.t("search.voice.permission_title"),'
\n
').concat(e.i18n.t("search.voice.permission_text"),"
\n
\n
\n
\n
\n
\n
\n
\n
\n \n \n \n \n \n \n
\n
\n
\n \n \n '.concat(e.i18n.t("search.voice.recognition_retry"),'\n
\n
\n
\n
\n
\n
\n ').concat(e.i18n.t("search.voice.trending_title"),'\n \n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
See Also
Cidara Therapeutics Inc (CDTX) Stock Price & News - Google FinanceCidara Therapeutics, Inc. (CDTX) Stock Price, Quote & News - Stock Analysis\n
\n
\n
\n
\n
NasdaqCM - Nasdaq Real Time Price • USD
At close: June 10 at 4:00 PM EDT
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
- Cidara Therapeutics to Present Preclinical Data on CD388 at ASM Microbe 2024 Conference SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced the company will be presenting a poster at the American Society for Microbiology (ASM) Microbe 2024 conference to be held June 13-17, 2024 at the Georgia World Congress Center in Atlanta
GlobeNewswire • 11 days ago
CDTX +4.60% - Ahorra en el iPhone 14 Plus. Amarillo maravilloso. Llévate el iPhone 14 Plus por nuestra cuenta. Con una linea nueva en ciertos planes Unlimited. (Unlimited Plus min. de $80/mes con Auto Pay (+...
Ad
Verizon
- Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today reported financial results for the first quarter ended March 31, 2024, and provided an update on its corporate activities and product pipeline. “Our reacquisition of our CD388 progra
GlobeNewswire • 26 days ago
CDTX +4.60% - Cidara Therapeutics Regains Compliance with Nasdaq Continued Listing Rules SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced that on May 14, 2024 it received a letter from the Listing Qualifications Department staff (the Staff) of the Nasdaq Stock Market LLC (Nasdaq) notifying the Company that it has regained
GlobeNewswire • 26 days ago
CDTX +4.60% - Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024 SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced two poster presentations highlighting data on CD388 at the 34th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) conference, being held April 27-30, 2024 in B
GlobeNewswire • last month
CDTX +4.60% -
Pharmaceutical Technology • last month
JNJ CDTX +4.60% - Amazon's Worst Nightmare: Thousands Canceling Prime for... This simple trick can save tons of money on Amazon, but most Prime members are ignoring it.
Ad
Online Shopping Tools
- Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million - $240 million private placement financing led by RA Capital Management with significant participation by Bain Capital Life Sciences as well as BVF Partners and Canaan Partners to fund Phase 2b clinical trial - CD388, which is active against all strains of influenza A and B, is being developed for pre-exposure prophylactic treatment - Company to host business strategy update conference call and webcast today at 4:30 PM ET SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (N
GlobeNewswire • last month
CDTX +4.60% - Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline Transaction provides company with an estimated approximately $128 million in cost savings, including approximately $67 million in clinical development and CMC costs over the next three years and an additional approximately $61 million in forecasted obligations through the patent life of rezafungin Cidara to further focus on advancing Cloudbreak development programs, including a planned IND filing for its lead oncology candidate, CBO421, as well as advancing other pipeline assets SAN DIEGO, April
GlobeNewswire • last month
CDTX +4.60% - Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided an update on its corporate activities and product pipeline. “2023 included sign
GlobeNewswire • last month
CDTX +4.60% - Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, announced on April 17, 2024, that the Company received a notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (Nasdaq) advising the Company that its failure to tim
GlobeNewswire • last month
CDTX +4.60% - Ashburn: 24 Hour Dental Implants Take our 1-minute quiz to find out if you're eligible for our revolutionary 24-hour dental implants. Get a new smile in just 24 Hrs
Ad
Nuvia
- Cidara Therapeutics Announces Reverse Stock Split SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced that the Company effected a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-20. The effective time of the reverse stock split will be
GlobeNewswire • last month
CDTX +4.60% - Cidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conjugate Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2024 - Multispecific CD73/PD-1 DFC demonstrates improved tumor reduction compared to PD-1 monotherapy in nonclinical study - CCR5-targeting DFC demonstrates potent efficacy in colorectal cancer mouse model - Late-breaking CBO421 data demonstrates improved efficacy compared to oleclumab in human triple-negative breast cancer cell lines SAN DIEGO, April 05, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop dr
GlobeNewswire • 2 months ago
CDTX +4.60% - Cidara Therapeutics to Present Preclincal Data on Multiple Novel Drug-Fc Conjugate Candidates at American Association for Cancer Research (AACR) Annual Meeting 2024 Abstracts to include preclinical data on several drug-Fc conjugate (DFC) candidates including multispecific CD73/PD-1 DFC, CCR5 targeting DFC and CBO421 (CD73 targeting DFC)SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced the company
GlobeNewswire • 3 months ago
CDTX +4.60% - Steven Cohen's Point72 Adds Cidara Therapeutics to Its Portfolio Steven Cohen (Trades, Portfolio)'s investment firm, Point72, has recently expanded its portfolio with the addition of Cidara Therapeutics Inc (NASDAQ:CDTX). On December 31, 2023, Point72 acquired 1,250,228 shares of the biotechnology company, reflecting a new position in the firm's diverse investment landscape. The transaction was executed at a trade price of $0.794 per share, marking a strategic move by one of the industry's leading investment entities.
GuruFocus.com • 3 months ago
CDTX +4.60% -
Ad
House Buyer Network
- Cidara Therapeutics Receives $11.14 Million Milestone Payment Following European Approval of REZZAYO Approval triggered by positive results from ReSTORE Phase III clinical trialPayment will advance Cidara’s Cloudbreak platform for the development of drug-Fc conjugates (DFCs) SAN DIEGO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced receipt of
GlobeNewswire • 3 months ago
CDTX +4.60% - Cidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidiasis in Adults The UK MHRA approval follows approvals by the U.S. FDA and the European CommissionCidara is entitled to receive a milestone payment of approximately $2.8 million from Mundipharma SAN DIEGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing therapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced that the United Kingdom (U.K.) Medicines and Healthcare products Regulatory Age
GlobeNewswire • 4 months ago
CDTX +4.60% - Cidara (CDTX) Up on EC Nod for Rezzayo in Invasive Candidiasis Cidara's (CDTX) Rezzayo (rezafungin acetate) gets approval from the European Commission for the treatment of invasive candidiasis in adults. The stock rises 11.1%.
Zacks • 5 months ago
CDTX +4.60% TRDA TARO - Cidara Therapeutics Announces European Approval of REZZAYO® (rezafungin) for the Treatment of Invasive Candidiasis in Adults Approval based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the STRIVE Phase II clinical trials and extensive nonclinical development program.REZZAYO represents the first new treatment option in over 15 years for patients with invasive candidiasis.Cidara is entitled to receive a milestone payment of approximately $11.14 million from Mundipharma for the European Medicines Agency (EMA) approval. SAN DIEGO, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeut
GlobeNewswire • 5 months ago
CDTX +4.60% - Lithium stock just signed a major JV and is set to soar With so much hype around this sector it's hard to know where to look. We've taken the guesswork out of the equation for you as you will see when...
Ad
Equity Insider
- Cidara Therapeutics Presents New Promising Preclincal Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress First in class, multi-specific CD73/PD-1 inhibitor DFC, exhibited robust anti-tumor activity in humanized mouse models of colorectal cancer at low doses CD73/PD-1 DFC demonstrated superior anti-tumor activity to CD73 and PD-1 monotherapies SAN DIEGO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care
GlobeNewswire • 6 months ago
CDTX +4.60% - Cidara Therapeutics Announces Completion of Enrollment in Phase 3 Restore Trial of Rezafungin in China Top-line data expected in Q2 2024 SAN DIEGO, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology developing therapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced the company, along with Mundipharma, has completed enrollment in the Phase 3 ReSTORE trial in China evaluating the efficacy and safety of rezafungin as a treatment for candidemia and invasive candidiasis. The portion of the trial co
GlobeNewswire • 6 months ago
CDTX +4.60% - Cidara Therapeutics to Present New Preclinical Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress Preclinical data on dual CD73/PD-1 targeting DFC to be presented for the first timeSAN DIEGO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced the company will present new preclinical data on its novel, dual-acting CD73/PD-1 targeting drug-Fc co
GlobeNewswire • 6 months ago
CDTX +4.60%
Performance Overview
Trailing total returns as of 6/10/2024, which may include dividends or other distributions. Benchmark is S&P 500
| Return | CDTX | S&P 500 |
|---|---|---|
| YTD | -15.43% | +12.39% |
| 1-Year | -44.50% | +24.70% |
| 3-Year | -69.48% | +27.05% |
